|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...678910111213141516...110111» |
- | Trial primary completion date: EC-02: The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma (clinicaltrials.gov) - Oct 10, 2017
P=N/A, N=240, Recruiting, Sponsor: Ding Ma
Trial primary completion date: Dec 2015 --> Dec 2017
- ||| progesterone / Generic mfg.
Trial completion: The Role of Progesterone and PIF for Successful Implantation and On-going Pregnancy in Assisted Reproductive Technology (clinicaltrials.gov) - Oct 9, 2017
P=N/A, N=873, Completed, Sponsor: Regionshospitalet Viborg, Skive
Trial primary completion date: Dec 2015 --> Dec 2017 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: Circadian Variation in Serum-progesterone Levels Following Controlled Ovarian Hyperstimulation. (clinicaltrials.gov) - Oct 9, 2017
P=N/A, N=10, Completed, Sponsor: Regionshospitalet Viborg, Skive
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2015
- | metformin / Generic mfg.
Trial completion: PregMet2: Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=489, Completed, Sponsor: Norwegian University of Science and Technology
Recruiting --> Completed | Trial primary completion date: Jul 2017 --> Dec 2015 Active, not recruiting --> Completed
- | Phase classification, Trial termination, Trial primary completion date: FIREFLY: Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=18, Terminated, Sponsor: Florida Hospital
Active, not recruiting --> Completed Phase classification: P4 --> P=N/A | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Jul 2016; Lack of funding
- | Trial completion, Trial primary completion date, MRI: Magnetic Resonance Imaging (MRI) Hysterosalpingography Versus Radiographic Hysterosalpingography in Female Infertility (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=40, Completed, Sponsor: Centre Hospitalier Universitaire de Nice
Phase classification: P4 --> P=N/A | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2015 --> Jul 2016; Lack of funding Recruiting --> Completed | Trial primary completion date: Sep 2014 --> Apr 2016
- | Phase classification: 3DRCT: Does 3D Laparoscopy Improve Vaginal Cuff Suture Time? (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=57, Completed, Sponsor: Brigham and Women's Hospital
Recruiting --> Completed | Trial primary completion date: Sep 2014 --> Apr 2016 Phase classification: P1 --> P=N/A
- | emtricitabine/tenofovir disoproxil fumarate / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date, Discordant: PrEP-HIVD: Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Missouri-Columbia
Phase classification: P1 --> P=N/A N=50 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2020 --> Sep 2017
- | lidocaine 5% / Generic mfg.
Trial completion, Enrollment change: Provoked, Localized Vulvodynia Treatment With Acupuncture and Lidocaine Pilot Study (clinicaltrials.gov) - Oct 6, 2017
P1, N=19, Completed, Sponsor: Oregon College of Oriental Medicine
N=50 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2020 --> Sep 2017 Active, not recruiting --> Completed | N=30 --> 19
- | Enrollment change, Trial withdrawal: Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia (clinicaltrials.gov) - Oct 6, 2017
P1, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed | N=30 --> 19 N=40 --> 0 | Not yet recruiting --> Withdrawn
- | Trial completion: Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE) (clinicaltrials.gov) - Oct 5, 2017
P=N/A, N=80, Completed, Sponsor: University of Alabama at Birmingham
N=40 --> 0 | Not yet recruiting --> Withdrawn Active, not recruiting --> Completed
- | cisplatin / Generic mfg., cyclophosphamide / Generic mfg., paclitaxel / Generic mfg.
Trial completion, Metastases: A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer (clinicaltrials.gov) - Oct 5, 2017
P2, N=47, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Avastin (bevacizumab) / Roche, lifastuzumab vedotin (DNIB0600A) / Roche
Trial completion, Enrollment change, Combination therapy: A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer (clinicaltrials.gov) - Oct 4, 2017
P1, N=41, Completed, Sponsor: Genentech, Inc.
No longer recruiting --> Completed Active, not recruiting --> Completed | N=33 --> 41
- || Zybrestat (fosbretabulin) / Oncotelic
Trial suspension: FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer (clinicaltrials.gov) - Oct 4, 2017
P2/3, N=436, Suspended, Sponsor: Mateon Therapeutics
Active, not recruiting --> Completed | N=33 --> 41 Active, not recruiting --> Suspended
- | Enrollment open, Enrollment change, Trial initiation date, Metastases: CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (clinicaltrials.gov) - Oct 4, 2017
P=N/A, N=100000, Recruiting, Sponsor: CureOne
Active, not recruiting --> Suspended Not yet recruiting --> Recruiting | N=150000 --> 100000 | Initiation date: May 2017 --> Oct 2017
- | sildenafil cream (SST-6006) / Daré Biosci, Strategic Science & Technologies
Trial completion, Trial primary completion date: Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder (clinicaltrials.gov) - Oct 3, 2017
P2a, N=31, Completed, Sponsor: Strategic Science & Technologies, LLC
Not yet recruiting --> Recruiting | N=150000 --> 100000 | Initiation date: May 2017 --> Oct 2017 Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017
- ||| Avastin (bevacizumab) / Roche
Enrollment open, Trial primary completion date, Combination therapy, Metastases: A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer (clinicaltrials.gov) - Oct 3, 2017
P=N/A, N=120, Recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed | Trial primary completion date: Dec 2016 --> May 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2017 --> Oct 2017
- | davamotecan pegadexamer (EP0057) / Ellipses Pharma, Avastin (bevacizumab) / Roche
Trial primary completion date, Combination therapy: CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer (clinicaltrials.gov) - Oct 2, 2017
P2, N=63, Active, not recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting | Trial primary completion date: Jul 2017 --> Oct 2017 Trial primary completion date: Mar 2017 --> Mar 2018
- | Trial suspension, Trial primary completion date: Desogestrel (DSG) and Corifollitropin(FSH-CTP) Alfa for Ovarian Stimulation in Donors (clinicaltrials.gov) - Oct 2, 2017
P4, N=35, Suspended, Sponsor: Institut Universitari Dexeus
Trial primary completion date: Mar 2017 --> Mar 2018 Not yet recruiting --> Suspended | Trial primary completion date: May 2017 --> Nov 2017
- | Clinical: Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis (clinicaltrials.gov) - Sep 29, 2017
P2, N=120, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Suspended | Trial primary completion date: May 2017 --> Nov 2017 Trial primary completion date: Jun 2017 --> Feb 2018
- | Trial primary completion date: EnMotion, Embryo's Natural Motion (clinicaltrials.gov) - Sep 28, 2017
P=N/A, N=200, Active, not recruiting, Sponsor: Reproductive Medicine Associates of New Jersey
Trial primary completion date: Jun 2017 --> Feb 2018 Trial primary completion date: Jul 2017 --> Dec 2017
- | Trial completion, Trial primary completion date, HEOR: Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer (clinicaltrials.gov) - Sep 28, 2017
P=N/A, N=14, Completed, Sponsor: City of Hope Medical Center
Trial primary completion date: Jul 2017 --> Dec 2017 Active, not recruiting --> Completed | Trial primary completion date: Apr 2018 --> Sep 2017
- | Avastin (bevacizumab) / Roche
Enrollment change, Trial termination: (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma (clinicaltrials.gov) - Sep 27, 2017
P2, N=7, Terminated, Sponsor: Western Regional Medical Center
Active, not recruiting --> Completed | Trial primary completion date: Apr 2018 --> Sep 2017 N=88 --> 7 | Recruiting --> Terminated; PI Decision
- | Trial primary completion date: Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer (clinicaltrials.gov) - Sep 26, 2017
P1, N=10, Recruiting, Sponsor: Sanjiv Sam Gambhir
N=88 --> 7 | Recruiting --> Terminated; PI Decision Trial primary completion date: Aug 2017 --> Jan 2018
- | Trial completion, Preclinical, Enrollment change: Use of Predictive Model to Assist Patients Having an Embryo Transfer After IVF (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=200, Completed, Sponsor: Ottawa Fertility Centre
Trial primary completion date: Aug 2017 --> Jan 2018 Recruiting --> Completed | N=276 --> 200
- Trial primary completion date: A Trial of Comparing the Pathology Status of Lymphoseek (clinicaltrials.gov) - Sep 25, 2017
P2, N=40, Recruiting, Sponsor: Cardinal Health 414, LLC
Recruiting --> Completed | N=276 --> 200 Trial primary completion date: Jul 2017 --> Oct 2018
- |||| Growtropin-II (somatropin biosimilar) - Dong / A
Trial primary completion date: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Sep 20, 2017
P3, N=58, Active, not recruiting, Sponsor: Dong-A ST Co., Ltd.
Trial primary completion date: Jul 2017 --> Oct 2018 Trial primary completion date: Jun 2016 --> May 2018
- ||| Visanne (dienogest) / Mochida, Bayer
Trial completion: Regulatory Post Marketing Surveillance Study in Korea (clinicaltrials.gov) - Sep 20, 2017
P=N/A, N=3223, Completed, Sponsor: Bayer
Trial primary completion date: Jun 2016 --> May 2018 Active, not recruiting --> Completed
- Odomzo (sonidegib) / Sun Pharma
Trial primary completion date: Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer (clinicaltrials.gov) - Sep 20, 2017
P1, N=15, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Trial primary completion date: Aug 2017 --> Dec 2017
- | metformin / Generic mfg.
Enrollment closed, Enrollment change: PregMet2: Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=489, Active, not recruiting, Sponsor: Norwegian University of Science and Technology
Trial primary completion date: Aug 2017 --> Dec 2017 Recruiting --> Active, not recruiting | N=1000 --> 489
- | Trial completion, Preclinical, Trial primary completion date: Optimising FSH Dosage During in Vitro Fertilization Fertilization (IVF) (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=196, Completed, Sponsor: Oslo University Hospital
Recruiting --> Active, not recruiting | N=1000 --> 489 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2017 --> Dec 2016
- | Trial completion: Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) - Sep 18, 2017
P3, N=566, Completed, Sponsor: Butler Hospital
Enrolling by invitation --> Completed | Trial primary completion date: Dec 2017 --> Dec 2016 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: Reducing HIV Risk Among Adolescents: Evaluating Project HEART (clinicaltrials.gov) - Sep 18, 2017
P=N/A, N=222, Completed, Sponsor: North Carolina State University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2016
- | Clinical data, Trial primary completion date: An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients (clinicaltrials.gov) - Sep 15, 2017
P=N/A, N=10, Enrolling by invitation, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> May 2016 Trial primary completion date: Dec 2017 --> Dec 2018
- | celecoxib oral / Generic mfg.
Trial completion, Trial primary completion date: Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia (clinicaltrials.gov) - Sep 15, 2017
P2, N=130, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Sep 2012
- ||| Trial completion: Furocyst - Poly Cystic Ovary Syndrome Study (clinicaltrials.gov) - Sep 15, 2017
P=N/A, N=107, Completed, Sponsor: Chemical Resources
Active, not recruiting --> Completed | Trial primary completion date: Jan 2100 --> Sep 2012 Recruiting --> Completed
- | Orgalutran (ganirelix acetate) / Organon
Trial completion: Progevera 10 mg® Versus Orgalutran® in Ovarian Stimulation Cycles of Oocyte Donors (clinicaltrials.gov) - Sep 13, 2017
P4, N=232, Completed, Sponsor: Fundació Privada Eugin
Recruiting --> Completed Recruiting --> Completed
- | polyvalent vaccine-KLH conjugate / MabVax, Avastin (bevacizumab) / Roche
Trial completion, Trial primary completion date, Combination therapy, IO biomarker: Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab (clinicaltrials.gov) - Sep 13, 2017
P=N/A, N=22, Completed, Sponsor: Memorial Sloan Kettering Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Oct 2018 --> Sep 2017
- | Trial completion, Phase classification, Trial primary completion date: Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy (clinicaltrials.gov) - Sep 12, 2017
P=N/A, N=24, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed | Trial primary completion date: Oct 2018 --> Sep 2017 Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Sep 2018 --> Sep 2017
- ||||||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Trial completion, Trial primary completion date: SOLITAIRE-U: Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea (clinicaltrials.gov) - Sep 11, 2017
P3, N=264, Completed, Sponsor: Cempra Inc
Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Sep 2018 --> Sep 2017 Recruiting --> Completed | Trial primary completion date: Aug 2017 --> Feb 2017
- | Trial completion, Phase classification, Enrollment change: Feasibility and Functional Outcome of Laparoscopic Nerve Sparing Radical Hysterectomy (clinicaltrials.gov) - Sep 11, 2017
P=N/A, N=46, Completed, Sponsor: Osama Mohammad Ali ElDamshety
Recruiting --> Completed | Trial primary completion date: Aug 2017 --> Feb 2017 Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A | N=30 --> 46
- | Enrollment open, Trial primary completion date: RESMO: Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy (clinicaltrials.gov) - Sep 8, 2017
P=N/A, N=90, Recruiting, Sponsor: University Hospital, Strasbourg, France
Enrolling by invitation --> Completed | Phase classification: P2/3 --> PN/A | N=30 --> 46 Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2018 --> Jan 2019
- || adavosertib (AZD1775) / AstraZeneca
Trial primary completion date, Combination therapy: A Study of Adavosertib (MK-1775) in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ovarian Tumors With the P53 Gene Mutation (MK-1775-004) (clinicaltrials.gov) - Sep 7, 2017
P2, N=136, Completed, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2018 --> Jan 2019 Trial primary completion date: Nov 2014 --> Aug 2016
- ||| Enrollment open: Aneuploidies in Embryos and Spermatozoa From Patients With Y-chromosome Microdeletions (clinicaltrials.gov) - Sep 6, 2017
P=N/A, N=300, Recruiting, Sponsor: Instituto Valenciano de Infertilidad, IVI Alicante
Trial primary completion date: Nov 2014 --> Aug 2016 Active, not recruiting --> Recruiting
- | polyvalent vaccine-KLH conjugate / MabVax
Trial completion, Trial primary completion date: OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission (clinicaltrials.gov) - Sep 6, 2017
P2, N=171, Completed, Sponsor: Gynecologic Oncology Group
Active, not recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Sep 2015
- | Merional (menotropin) / IBSA Institute Biochemical SA, Choriomon (human choriomon gonadotropin (hCG)) / IBSA Institute Biochemical SA
Trial completion, Enrollment change: AIPRICSI: Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI (clinicaltrials.gov) - Sep 6, 2017
P4, N=50, Completed, Sponsor: Minia University
Active, not recruiting --> Completed | Trial primary completion date: Feb 2015 --> Sep 2015 Recruiting --> Completed | N=20 --> 50
- | Trial completion, Enrollment change: Identifying Expression Markers of Cumulus Cells to Identify Oocyte Developmental Potential Through a Maturation Analysis (clinicaltrials.gov) - Sep 5, 2017
P=N/A, N=200, Completed, Sponsor: Memorial Sisli Hospital, Istanbul
Recruiting --> Completed | N=20 --> 50 Recruiting --> Completed | N=250 --> 200
- | Trial primary completion date: Transperineal Ultrasound to Assess the Progress of Labour (clinicaltrials.gov) - Sep 5, 2017
P=N/A, N=700, Recruiting, Sponsor: Imperial College London
Recruiting --> Completed | N=250 --> 200 Trial primary completion date: Apr 2017 --> Apr 2018
- | Trial completion, Enrollment change, Trial primary completion date: Prevention of HPV in the School Health Service (clinicaltrials.gov) - Sep 5, 2017
P=N/A, N=832, Completed, Sponsor: Uppsala University
Trial primary completion date: Apr 2017 --> Apr 2018 Active, not recruiting --> Completed | N=1050 --> 832 | Trial primary completion date: Mar 2016 --> Aug 2017
- | Trial primary completion date: Sentinel Lymph Node Detection in Endometrial Cancer (clinicaltrials.gov) - Sep 5, 2017
P=N/A, N=375, Recruiting, Sponsor: Region Skane
Active, not recruiting --> Completed | N=1050 --> 832 | Trial primary completion date: Mar 2016 --> Aug 2017 Trial primary completion date: Jun 2017 --> Jun 2019